From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Members are the core strength of AZBio. Do you know someone that could benefit by being part of our community? Refer them to AZBio and get a chance to win a Kindle Fire®.
AZBio partners with LexisNexis and State Net to bring you all the latest updates from Washington DC and around the nation. Check out the latest in the February 6, 2012 edition.
ASU Biodesign Team explores radically new approach for developing viable lung tissue suitable for transplantation.
AdvaMed’s Stephen J. Ubl Shares Comments Regarding the Release of Proposed IRS Regs to Implement Medical Device Tax and Underscores Need for Swift Repeal
- UA Sequencing Core Launch Party
- AZBio Summer Social 2019 at GlobalMed
- Laws of Innovation Series: Negotiating Patent and Know-How License Agreements
- BIO Latin America
- 09/03/2019 - 09/04/2019
- São Paulo
- The Rocky Mountain Life Science Investor & Partnering Conference
- 09/04/2019 - 09/05/2019